<div id="readability-page-1"><p>Microbot Medical received a Buy rating and a $5.50 price target from Roth MKM analyst Kyle Bauser today.</p><h3>TipRanks Cyber Monday Sale</h3><ul><li> Claim 60% off TipRanks Premium  for data-backed insights and research tools you need to invest with confidence.  </li><li>  Subscribe to TipRanks' Smart Investor Picks  and see our data in action through our high-performing model portfolio - <u> now also 60% off </u></li></ul> <p>Bauser covers the Healthcare sector, focusing on stocks such as Sanuwave Health, HeartBeam, and Electromed. According to TipRanks, Bauser has an average return of <span>-12.3%</span> and a 37.93% success rate on recommended stocks. </p> <p>Currently, the analyst consensus on Microbot Medical is a Moderate Buy with an average price target of $8.75.</p></div>

MBOT

<p>Roth MKM analyst Kyle Bauser has given Microbot Medical (MBOT) a Buy rating with a $5.50 price target. Bauser, who covers the Healthcare sector, has an average return of -12.3% and a 37.93% success rate on recommended stocks. The analyst consensus on Microbot Medical is a Moderate Buy with an average price target of $8.75.</p>

Microbot Medical (MBOT) Receives a Buy from Roth MKM